Our company news

Smooth is meeting its customers at BIO Europe 2014 in Frankfurt-am-Main

Published on Tuesday September 30, 2014

Smooth Drug Development is meeting its customers at BIO Europe 2014 in Frankfurt-am-Main.

Read more →

Sustainable development as a contribution to medicine and R&D

Published on Friday September 19, 2014

Smooth Drug Development: sustainable development as a contribution to medicine and R&D.

Read more →

Smooth Drug Development initiates a new clinical trial in Armenia

Published on Wednesday August 20, 2014

Smooth Drug Development team announces a new clinical trial start in Armenia.

Read more →

We attend Bio Convention 2014 in San Diego

Published on Wednesday August 20, 2014

Smooth Drug Development team is to attend one of the biggest events, Bio Convention in San Diego 2014.

Read more →

Smooth Drug Development performs GCP trainings

Published on Thursday May 29, 2014

Smooth Drug Development invites you to attend a training GCP: Basics. Practical Aspects of Monitoring in Clinical Trials. Audit and Inspections Findings.

Read more →

Karina Semenova joined Smooth

Published on Tuesday May 13, 2014

Karina Semenova headed Quality Assurance and Trainings department of Smooth Drug Development.

Read more →

Performed a bioequivalence study

Published on Wednesday March 26, 2014

Smooth Drug Development has completed a bioequivalence clinical trial with a drug for HIV treatment.

Read more →

Performed a phase I study

Published on Tuesday March 25, 2014

Smooth Drug Development has completed a phase I study with a erythropoiesis stimulator in healthy volunteers.

Read more →

Two large-scale observational studies

Published on Monday March 24, 2014

Smooth Drug Development is performing two large-scale observational studies for a top ten company

Read more →

Smooth participated in the opening ceremony of phase I unit BioEq

Published on Friday March 21, 2014

Smooth Drug Development participated in the opening ceremony of clinical pharmacology phase I unit for early stage trials.

Read more →

Performed a phase I PK and PD study

Published on Wednesday March 19, 2014

Smooth Drug Development has completed a phase I PK and PD study of a anticoagulant treatment in healthy volunteers.

Read more →

Developing a polysaccharide pneumococcal vaccine

Published on Monday March 17, 2014

Smooth Drug Development expands its experience in vaccine clinical studies.

Read more →

Performing a bioequivalence trial of a sedative drug

Published on Thursday March 06, 2014

Smooth Drug Development is performing a bioequivalence study of a sedative drug in healthy volunteers.

Read more →

New commercial R&D unit for early phase

Published on Thursday February 27, 2014

Smooth Drug Development participates at opening of the new commercial R&D unit for early phase clinical research.

Read more →

Developing vaccine against pathogenic streptococcus

Published on Monday February 03, 2014

Smooth Drug Development is working on an innovative vaccine for treatment of pathogenic streptococcus.

Read more →